With a percutaneous femoral approach, iVAC2L can support with a pulsatile flow patients with impaired left ventricular function who require a mechanical circulatory support as bridge to decision or bridge to bridge (left ventricle assist device).1The use of the iVAC2L is found to be effective in high risk percutaneous coronary intervention (PCI) procedures.2
Maintain Cardiac Output and Coronay Perfusion by pulsatile iVAC2L - percutaneous Ventricular Assist Device1.
Increasing cardiac output with up to 2l/min, iVAC2L helps to maintain the coronay and end-organ perfusion.
Single lumen Nitinol braided catheter with proprietary bi-directional valve and an extracorporeal membrane pump ensure efficient pump performance at straightforwad technology2. The working principle helps to provide a low hemolysis rate. (fHb<6µmol/l)1.
Ease of use and short learning curve- helps a fast adoption in daily practice2.
Advance iVAC2L catheter following standard LV positioning practice.3
Connect membrane pump to catheter and IABP driver.3
Start the support and focus on your supported Complex PCI.3
iVAC2L is a trademark of PulseCath b.v., The NetherlandsiVAC2L is manufactured by PulseCath b.v. and exclusively distributed by Terumo Europe NV in EMEA territory1 Pulsatile iVAC2L Circulatory Support in High-Risk Percutaneous Coronary Intervention; Corstiaan A den Uil, MD, PhD; J Daemen, MD, PhD; MJ Lenzen, PhD; AM Maugenest, MSc; L Joziasse, MSc; RJ van Geuns, MD, PhD; Nicolas M. VanMieghem, MD, PhD, Eurointervention in Press2 The PulseCath iVAC2L left ventricular assist device: conversion to a percutaneous transfemoral approach. Van Mieghem N.M., et al. Euro Intervention 2015; 1:835-8393 IFU iVAC2L 10Feb2014